123 related articles for article (PubMed ID: 36027604)
1. Colletofragarone A2 Inhibits Cancer Cell Growth
Sadahiro Y; Hitora Y; Kimura I; Hitora-Imamura N; Onodera R; Motoyama K; Tsukamoto S
Chem Res Toxicol; 2022 Sep; 35(9):1598-1603. PubMed ID: 36027604
[TBL] [Abstract][Full Text] [Related]
2. Colletofragarone A2 and Colletoins A-C from a Fungus
Sadahiro Y; Hitora Y; Tsukamoto S
J Nat Prod; 2021 Dec; 84(12):3131-3137. PubMed ID: 34854682
[TBL] [Abstract][Full Text] [Related]
3. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition.
Aggarwal M; Saxena R; Asif N; Sinclair E; Tan J; Cruz I; Berry D; Kallakury B; Pham Q; Wang TTY; Chung FL
J Exp Clin Cancer Res; 2019 Jul; 38(1):307. PubMed ID: 31307507
[TBL] [Abstract][Full Text] [Related]
4. Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53.
Song B; Wang J; Ren Y; Su Y; Geng X; Yang F; Wang H; Zhang J
Biomed Pharmacother; 2023 Jul; 163():114773. PubMed ID: 37156116
[TBL] [Abstract][Full Text] [Related]
5. Plakoglobin restores tumor suppressor activity of p53
Alaee M; Nool K; Pasdar M
Cancer Sci; 2018 Jun; 109(6):1876-1888. PubMed ID: 29660231
[TBL] [Abstract][Full Text] [Related]
6. The gain of function of p53 cancer mutant in promoting mammary tumorigenesis.
Lu X; Liu DP; Xu Y
Oncogene; 2013 Jun; 32(23):2900-6. PubMed ID: 22824795
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.
Dong P; Xu Z; Jia N; Li D; Feng Y
Mol Cancer; 2009 Nov; 8():103. PubMed ID: 19917135
[TBL] [Abstract][Full Text] [Related]
8. Dynamics and Molecular Mechanisms of p53 Transcriptional Activation.
Offutt TL; Ieong PU; Demir Ö; Amaro RE
Biochemistry; 2018 Nov; 57(46):6528-6537. PubMed ID: 30388364
[TBL] [Abstract][Full Text] [Related]
9. USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells.
Padmanabhan A; Candelaria N; Wong KK; Nikolai BC; Lonard DM; O'Malley BW; Richards JS
Nat Commun; 2018 Mar; 9(1):1270. PubMed ID: 29593334
[TBL] [Abstract][Full Text] [Related]
10. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent.
Whitesell L; Sutphin PD; Pulcini EJ; Martinez JD; Cook PH
Mol Cell Biol; 1998 Mar; 18(3):1517-24. PubMed ID: 9488468
[TBL] [Abstract][Full Text] [Related]
11. Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells.
Kogan-Sakin I; Tabach Y; Buganim Y; Molchadsky A; Solomon H; Madar S; Kamer I; Stambolsky P; Shelly A; Goldfinger N; Valsesia-Wittmann S; Puisieux A; Zundelevich A; Gal-Yam EN; Avivi C; Barshack I; Brait M; Sidransky D; Domany E; Rotter V
Cell Death Differ; 2011 Feb; 18(2):271-81. PubMed ID: 20689556
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics study on the inhibition mechanisms of ReACp53 peptide for p53-R175H mutant aggregation.
Lei J; Cai M; Shen Y; Lin D; Deng X
Phys Chem Chem Phys; 2021 Oct; 23(40):23032-23041. PubMed ID: 34612239
[TBL] [Abstract][Full Text] [Related]
13. Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells.
Li D; Marchenko ND; Schulz R; Fischer V; Velasco-Hernandez T; Talos F; Moll UM
Mol Cancer Res; 2011 May; 9(5):577-88. PubMed ID: 21478269
[TBL] [Abstract][Full Text] [Related]
14. Mutations in DNA binding domain of p53 impede RSL1D1-p53 interaction to escape from degradation in human colorectal cancer cells.
Ding L; Zhao C; Xu Y; Zhang Z; Nie Y; Liao K; Chen Y; Tu B; Zhang X
Exp Cell Res; 2022 Aug; 417(1):113211. PubMed ID: 35597299
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of mutant p53 by capsaicin, the major constituent of peppers.
Garufi A; Pistritto G; Cirone M; D'Orazi G
J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722
[TBL] [Abstract][Full Text] [Related]
16. A common gain of function of p53 cancer mutants in inducing genetic instability.
Liu DP; Song H; Xu Y
Oncogene; 2010 Feb; 29(7):949-56. PubMed ID: 19881536
[TBL] [Abstract][Full Text] [Related]
17. Andrographolide induces degradation of mutant p53 via activation of Hsp70.
Sato H; Hiraki M; Namba T; Egawa N; Baba K; Tanaka T; Noshiro H
Int J Oncol; 2018 Aug; 53(2):761-770. PubMed ID: 29845212
[TBL] [Abstract][Full Text] [Related]
18. Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature.
Solomon H; Buganim Y; Kogan-Sakin I; Pomeraniec L; Assia Y; Madar S; Goldstein I; Brosh R; Kalo E; Beatus T; Goldfinger N; Rotter V
J Cell Sci; 2012 Jul; 125(Pt 13):3144-52. PubMed ID: 22427690
[TBL] [Abstract][Full Text] [Related]
19. Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP.
Wang J; Zhao Q; Qi Q; Gu HY; Rong JJ; Mu R; Zou MJ; Tao L; You QD; Guo QL
J Cell Biochem; 2011 Feb; 112(2):509-19. PubMed ID: 21268072
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells.
Cao Y; Gao Q; Wazer DE; Band V
Cancer Res; 1997 Dec; 57(24):5584-9. PubMed ID: 9407971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
